Apyx Leadership Tuesday, September 29, 2026 +0.50 Positive

Renuvion clinical study confirms skin quality improvements

Results published in Plastic and Reconstructive Surgery show Renuvion significantly increased elastin density and reduced inflammation. CEO Goodwin stated this validates the technology for broader aesthetic use.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed